ロード中...
Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury
Myocardial ischemia/reperfusion (I/R) injury is a major cause of mortality and morbidity worldwide. Among factors contributing to I/R injury, proteolytic enzymes could also cause cellular injury, expand the injured area and induce inflammation, which then lead to cardiac dysfunction. Therefore, prot...
保存先:
| 出版年: | Biomedicines |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8070046/ https://ncbi.nlm.nih.gov/pubmed/33924676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9040422 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|